Renal antioxidant enzymes and fibrosis-related markers in the rat adriamycin model.
Excessive generation of reactive oxygen intermediates can induce changes in the cellular antioxidant defence system. In this study we examine the antioxidant enzyme status and the expression of fibrosis-related marker proteins in the Adriamycin model of chronic renal failure in the rat. Twenty weeks after Adriamycin treatment, rats have overt nephrotic syndrome and renal failure with development of tubulo-interstitial fibrosis and glomerulosclerosis. Lipids accumulate in blood and in both glomeruli and tubulo-interstitial tissue. Desmin and alpha-smooth muscle actin expression increases in glomeruli and in the tubulo-interstitial area. Renal cortex antioxidant enzyme activities are decreased 20 weeks after Adriamycin injection (to 41% for catalase, to 56% for total superoxide dismutase and to 69% for glutathione peroxidase). The mRNA levels of catalase, Cu/Zn-superoxide dismutase and glutathione peroxidase-1 evaluated by Northern blot are decreased by more than 50% for catalase, Cu/Zn-superoxide dismutase and glutathione peroxidase-1. We conclude that in the rat Adriamycin-induced model of chronic renal failure with fibrosis, the combination of decreased antioxidant enzyme status in renal cortex with high concentrations of lipids in blood and renal tissue facilitates oxidative damage. Development of fibrosis is paralleled by increased expression of desmin and alpha-smooth muscle actin.
Van den Branden
C
C
Department of Human Anatomy, Vrije Universiteit Brussel, Belgium. cvdbrand@minf.vub.ac.be
Ceyssens
B
B
De Craemer
D
D
Pauwels
M
M
Vanden Houte
K
K
De Bleser
P
P
Hellemans
K
K
Geerts
A
A
Verbeelen
D
D
D000818:Animals; D015415:Biomarkers / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D002374:Catalase / Q000235:genetics / Q000378:metabolism*; D003893:Desmin / Q000032:analysis / Q000235:genetics; D004317:Doxorubicin / Q000633:toxicity*; D005355:Fibrosis; D005979:Glutathione Peroxidase / Q000235:genetics / Q000378:metabolism*; D006439:Hemodynamics / Q000187:drug effects; D007668:Kidney / Q000187:drug effects / Q000201:enzymology* / Q000473:pathology*; D007672:Kidney Cortex / Q000201:enzymology; D008297:Male; D023421:Models, Animal; D009404:Nephrotic Syndrome / Q000139:chemically induced / Q000201:enzymology / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar; D012016:Reference Values; D051437:Renal Insufficiency / Q000139:chemically induced / Q000201:enzymology / Q000473:pathology; D013482:Superoxide Dismutase / Q000235:genetics / Q000378:metabolism*; D013997:Time Factors; D014158:Transcription, Genetic
D015415:Biomarkers; D003893:Desmin; D004317:Doxorubicin; D002374:Catalase; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase